Centene stock
Price history
+97.48% over the period1 year: from $36.09 (November 13, 2025) to $71.27 (November 13, 2026), +97.48%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 13, 2026 | $71.27 |
| October 30, 2026 | $68.45 |
| September 30, 2026 | $62.12 |
| August 31, 2026 | $64.34 |
| July 31, 2026 | $62.22 |
| June 30, 2026 | $64.19 |
| May 29, 2026 | $59.60 |
| April 30, 2026 | $53.69 |
| March 31, 2026 | $32.74 |
| February 27, 2026 | $44.88 |
| January 30, 2026 | $43.32 |
| December 31, 2025 | $41.15 |
| November 28, 2025 | $39.34 |
| November 13, 2025 | $36.09 |
At a glance
The company
Manages health insurance programs and services for under-insured families and organizations across Medicaid, Medicare, Commercial and other segments
Latest results
Quarter to September 30, 2026 · EPS $0.58 (estimate $0.10)
Next event
TickerLandia's take on Centene
- Pricier than similar companies: trailing 12-month P/E 23 vs 18 (+25%) in a group of 7.
- Strong point: Market momentum (86/100 in its group). Weak point: Profitability (15/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−1.70% from the 52-week high
Analysts · 21 analysts
Average target$73.50+3.13% vs. price
Buy 8 · Hold 12 · Sell 1 · Buy
TickerLandia Fingerprint: Centene
Compared with similar companies: very strong momentum, very low profitability, and very low price.
Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 883 North American stocks.
Pricevery low20
How much it costs relative to what it produces.
Metric Value Position in group Price/book 1.53 19 Price/sales 0.19 3 EV/EBITDA 6.42 1 P/E (trailing 12 months) 22.8 46 Forward P/E 13.5 28 Profitabilityvery low15
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 1.9% 17 ROA 2.7% 10 ROE 6.7% 22 Gross margin 11.3% 13 Net margin 0.8% 15 Earnings stabilitylow23
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 2.5% 33 Loss-making yearscounts in reverse: lower means more earnings stability 1 of 5 annual reports 13 Growthlow21
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +10.45% 44 Revenue growth (year over year) +0.20% 13 Earnings growth (year over year) −98.94% 6 Financial strengthaverage53
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 0.11 84 Current ratio 1.16 51 Interest coverage 1.90 16 Debt/equitycounts in reverse: lower means more financial strength 0.70 59 Dividendno dividend
How much it returns to shareholders, and for how long.
Market momentumvery strong86
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +11.31% 77 Relative strength (6 months) +19.31% 77 1-year return +97.48% 98 Distance from 200-day average +25.85% 93 Riskaverage54
How much the price swings.
Metric Value Position in group Volatility (60 days) 40.4% 64 Beta (1 year) 0.48 40 Maximum drawdown (12 months) 32.7% 59
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Centene is pricier than similar companies
Centene's P/E (trailing 12 months): 22.8, +25% against the median of a group of 7 similar companies (18.3).
Compared with 7 similar companies
| Metric | Centene | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 22.8 | Middle | |
| Forward P/E | 13.5 | Middle | |
| Operating margin | 1.9% | Low | |
| ROE | 6.7% | Low | |
| Debt/equity | 0.70 | Middle |
Grey band: the middle half of the group; tick: the median; dot: Centene. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$50.65B
Latest quarter · Q3 2026
Net income
-$71M
Latest quarter · Q3 2026
Quarterly net margin
-0.1%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $33.52B
- P/E
- 22.8
- EPS
- $2.95
- Volume
- 2.54M
- Daily trading
- €369.88M
How Centene is changing
All resultsRevenue grew 11.9% a year on average over the last 5 years
Operating margin fell from 0.9% to −3.9%
Shares outstanding down 14.9% in 5 years
Returns
Centene returns
$1,000 invested in Centene 5 years ago, on November 15, 2021, would be worth $949 today: −5.10% in total, −1.04% per year. This is the price return only: dividends are excluded.
| Period | Centene | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +3.50% | −3.12% | $1,035 |
| 6 months | +21.19% | +1.58% | $1,212 |
| Year to date | +73.20% | +10.46% | $1,732 |
| 1 year | +97.48% | +12.23% | $1,975 |
| 3 years | −1.21% | +71.41% | $988 |
| 5 years | −5.10% | +61.48% | $949 |
| 10 years | +176.40% | +249.40% | $2,764 |
Over the last 6 months it has done better than 58% of the stocks in the Healthcare sector.
Price only, without dividends. Calculate your investment
The chart in detail
Centene: technical analysis
Centene is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 26.7% below its all-time closing high ($97.22, August 15, 2022).
- Trend
- Upward
- RSI (14 sessions)
- 55
- Between 30 and 70
- vs 200-session average
- +25.85%
Support and resistance
Price areas where Centene has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last price$71.27
- Support$69.10−3.05%5 touches, last on September 14, 2026
- Support$62.98−11.64%4 touches, last on September 9, 2026
- Support$60.04−15.76%3 touches, last on October 1, 2026
Volatility and risk
Over the last year it has moved less than the S&P 500.
- Beta (1 year) vs S&P 500
- 0.48
- Volatility (60 sessions, annualised)
- 40.4%
- Largest fall in the last year
- −32.73%
Close of November 13, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Centene: seasonality
Average monthly price change over 25 years
Over the last 25 years, the strongest month for Centene has been November: +5.46% on average, positive in 19 years out of 24. The weakest has been July: −1.75% on average, positive in 11 years out of 25.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +1.30% | +1.48% | 15 of 25 |
| February | −1.70% | −2.92% | 11 of 25 |
| March | +2.15% | +1.90% | 17 of 25 |
| April | +4.14% | +1.60% | 14 of 25 |
| May | +4.52% | +1.43% | 16 of 25 |
| June | +1.49% | +3.89% | 15 of 25 |
| July | −1.75% | −0.67% | 11 of 25 |
| August | −0.34% | −2.80% | 12 of 25 |
| September | +0.88% | −1.06% | 12 of 25 |
| October | +3.72% | +1.32% | 15 of 25 |
| November | +5.46% | +6.47% | 19 of 24 |
| December | +2.81% | +3.12% | 15 of 24 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Centene and its competitors
Centene serves low-income families, people with disabilities, older adults and commercial customers across the United States through managed care programs delivered by public and private health plans. Its Medicaid business covers temporary assistance for needy families, Medicaid expansion, children's health insurance and long-term services, while its Medicare arm offers special needs, supplement and prescription drug plans.
- Headquarters
- Saint Louis, United States
- Employees
- 61,100
- Founded
- 1984
- Chief executive
- Sarah London
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| CenteneCNC | $33.52B | 1.9% | 22.8 | +21.19% |
| HumanaHUM | $50.12B | 2.3% | 39.0 | +47.61% |
| Cigna GroupCI | $78.26B | 3.8% | 13.1 | −1.23% |
| Elevance HealthELV | $92.88B | 4.0% | 18.3 | +7.52% |
| CVS HealthCVS | $114.32B | 3.1% | 10.4 | −8.93% |
| UnitedHealth GroupUNH | $365.09B | 5.9% | 23.3 | +1.57% |
Same industry or related industries, similar size. Compare Centene with its competitors · Full profile
